1H and 13C NMR spectral data of p‐nitrobenzenesulfonamides and dansylsulfonamides derived from N‐alkylated o‐(purinemethyl)anilines

In recent years, purine bases have been the subject of extensive research that led to the discovery of thousands of biological active compounds, including antineoplastic ones. We synthesized a novel series of alkylated purines (1-9) with notable in vitro antiproliferative activities, low toxicity and systemic distribution after oral administration in vivo. The design of these compounds was based on the modifications of acyclic O,N-acetals, previously described by our research group as anti-proliferative agents. We have also prepared the 5-fluorouracil (5-FU) derivative (10) as a prototype compound. Finally, the fluorescent analogous (11-14) of the most active compounds were synthesized in order to study the in vitro and in vivo drug distributions. The pnitrobenzenesulfonyl group was interchanged with the dansyl group as a chromophore because of its similarity. Moreover, a fluorescence study of some anti-tumour drugs with a dansyl [5-(dimethylamino)naphthalene-1-sulfonyl] group in their structure that present no toxicity in vivo confirms the use of this chromophore in the design. Although the structure of these derivatives was determined by means of standard spectroscopic techniques (H, C NMR and MS), a detailed NMR study has been performed in order to unequivocally corroborate their structures. Herein, we report the H and C NMR unequivocal assignments of a series of anti-proliferative compounds. The spectra of the precursors and intermediate derivatives of the synthesis pathway for their preparation are also included.

[1]  J. Marchal,et al.  p-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o-(purine-methyl)anilines as novel antitumour agents , 2015 .

[2]  V. Kryštof,et al.  Synthesis of Novel N9-Substituted Purine Derivatives from Polymer Supported α-Amino Acids. , 2015, ACS combinatorial science.

[3]  M. Torres,et al.  Synthesis and Pharmacophore Modelling of 2,6,9-Trisubstituted Purine Derivatives and Their Potential Role as Apoptosis-Inducing Agents in Cancer Cell Lines , 2015, Molecules.

[4]  Z. Demir,et al.  Synthesis of novel substituted purine derivatives and identification of the cell death mechanism. , 2015, European journal of medicinal chemistry.

[5]  J. Marchal,et al.  Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines. , 2014, European journal of medicinal chemistry.

[6]  A. Martínez-Amat,et al.  The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis. , 2012, European journal of medicinal chemistry.

[7]  H. Boulaiz,et al.  Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine. , 2011, European journal of medicinal chemistry.

[8]  J. Campos,et al.  Synthesis of Purine Derivatives as Scaffolds for a Diversity of Biological Activities , 2010 .

[9]  R. Gambari,et al.  5-(Dimethylamino)-N-(4-ethynylphenyl)-1-naphthalenesulfonamide as a novel bifunctional antitumor agent and two-photon induced bio-imaging probe. , 2010, Chemical communications.

[10]  J. Marchal,et al.  Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies. , 2008, Bioorganic & medicinal chemistry letters.

[11]  J. Prados,et al.  Chemical modifications on the acyclic moiety of 3-(2-hydroxyethoxy)-1-alkoxypropyl nucleobases. 2. Differentiation and growth inhibition in rhabdomyosarcoma cells after exposure to a novel 5-fluorouracil acyclonucleoside , 1997 .

[12]  H. Boulaiz,et al.  New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. , 2011, European journal of medicinal chemistry.

[13]  J. Marchal,et al.  6′-Chloro-7- or 9-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-7H- or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs , 2007 .